Phase 3 N=46 Two Different Antibiotic Agents to Treat Generalized Aggressive Periodontitis
Aggressive Periodontitis
Primary: Change in Clinical Attachment Level (CAL) — 3.69; 3.62; 2.4; 3 mm
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=5 An Open-Label, Phase 2a Study to Evaluate Safety and Efficacy of GR-MD-02 for Treatment of Psoriasis
Psoriasis
Primary: Number of Participants With PASI-75, or a 75% Improvement From Baseline in PASI Score — 1 Participants
N/A N=31 Clinical Assessment and Thickness Changes of the Oblique and Multifidus Muscles
Abdominal Muscles
Primary: Changes in Muscle Thickness — .820; .671 centimeters
N/A N=13 Bevacizumab w / Temozolomide PET & Vascular MRI For GBM
Recurrent Glioblastoma
Primary: Number of Patients With a Decrease in Median Tumor SUV — 6 Participants
N/A N=86 Randomized Evaluation of the Efficacy of Synvisc-One® for the Treatment of Patellofemoral Chondromalacia
Chondromalacia Patella · Patellofemoral Pain Syndrome
Primary: Knee Pain During a Single Leg Squat — 5.6; 5.2; 4.1; 3.4 units on a scale
Phase 2 N=48 Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients
Narcolepsy
Primary: Epworth Sleepiness Scale (ESS) — 14.68; 15.34; 15.34 score on a scale
N/A N=20 Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease II
Peripheral Arterial Disease
Primary: Clinical Success — 20 Participants
N/A N=20 Comparison of One-port and Two-port Tissue Expanders for Breast Reconstruction
Breast Cancer
Primary: Number of Participants With Successful Replacement of Tissue Expander With Permanent Implant — 8; 12 Participants
N/A N=67 Variations in Palatability and Portion Size of Vegetables on Meal Intake of Preschool Children
Feeding Behavior
Primary: Difference Between Interventions in Vegetable Intake — 32; 57; 31; 50 grams — p=0.1260
N/A N=38 Examining the Association Between Pre-existing Sleep Disturbance and Postoperative Delirium
Delirium
Primary: Association Between Sleep and POD — 278.5; 313.5 Minutes
N/A N=84 The cryoICE™ CryoAnalgesia Study For Pain Management in Post thoRacic Procedures Via intercOSTal Cryoanalgesia (FROST)
Pain
Primary: Primary Outcome 1: Forced Expiratory Volume (FEV1) at 48-Hours Post-Surgery — 1.2; 0.93 Liters (L) — p=0.0223
Phase 3 N=462 Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis
Actinic Keratoses
Primary: Percentage of Subjects in Each Treatment Group With Complete Clearance of AK Lesions at the Test of Cure Visit (Week 24) — 74; 72; 7 Participants — p=0.0001
N/A N=343 Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14
NASH - Nonalcoholic Steatohepatitis · Cirrhosis · Portal Hypertension
Primary: Number of Subjects With Matched Clinically Significant Portal Hypertension Based on Hepatic Venous Pressure Gradient (HVPG) and Methacetin Breath Test (MBT) — 190…
N/A N=83 New Glucose Sensor Pediatric
Type 1 Diabetes Mellitus
Primary: Glucose Sensor Accuracy When Compared to SMBG: Proportion of Glucose Sensor Readings That Met Accuracy Criteria [Time Frame: Days One Through Six of Sensor Use] — 72.4 %…
Phase 2 N=22 Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide
Actinic Keratosis
Primary: PGA Score — 0.53 score on a scale